My Experience and Comprehension of Flebogrif®, a New Modalityof Mechanochemical Ablation for Incompetent Saphenous Veins –What’s Different from ClariVein®?
10.37923/phle.2024.22.1.36
- Author:
Insoo PARK
1
;
Sujin PARK
Author Information
1. Charm Vascular Clinic, Seoul, Korea
- Publication Type:Brief Communication
- From:
Annals of phlebology
2024;22(1):36-38
- CountryRepublic of Korea
- Language:English
-
Abstract:
Flebogrif® is a new modality of mechanochemical ablation for incompetent saphenous vein treatment. With our experiences, it offers advantages such as reduced sclerosant dosage, shorter procedure times, lower catheter costs and in terms of closure rate as well. However, the potential for increased pain and thrombophlebitis due to more potent mechanical injury is apparent.
